Archives of Medical Research
Volume 37, Issue 6 , Pages 749-754 , August 2006

Increased Insulin Levels Independent of Gestational Overweight in Women with Preeclampsia

Received 17 August 2005 ,Accepted 20 December 2005.

References 

  1. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy . Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183:S1–S22
  2. Skjaerven R, Wilcox AJ, Lie RT. The interval between pregnancies and the risk of preeclampsia. N Engl J Med. 2002;346:33–38
  3. Odendaal HJ, Pattinson RC, Bam R, Grove D, Kotze TJW. Aggressive or expectant management for patients with severe preeclampsia between 28–34 weeks' gestation: a randomized controlled trial. Obstet Gynecol. 1990;76:1070–1075
  4. Sibai BM, Gordon T, Thom E, Caritis SN, Klebanoff M, McNellis D, et al. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. Am J Obstet Gynecol. 1995;172:642–648
  5. Sowers JR, Saleh AA, Sokol RJ. Hyperinsulinemia and insulin resistance are associated with preeclampsia in African-Americans. Am J Hypertens. 1995;8:1–4
  6. Martinez-Abundis E, Gonzalez-Ortiz M, Quiñones-Galvan A, Ferrannini E. Hyperinsulinemia in glucose-tolerant women with preeclampsia. A controlled study. Am J Hypertens. 1996;9:610–614
  7. Barden A, Singh R, Walters BN, Ritchie J, Roberman B, Beilin LJ. Factors predisposing to pre-eclampsia in women with gestational diabetes. J Hypertens. 2004;22:2371–2378
  8. Yogev Y, Xenakis EM, Langer O. The association between preeclampsia and the severity of gestational diabetes: the impact of glycemic control. Am J Obstet Gynecol. 2004;191:1655–1660
  9. Roberts RN, Henriksen JE, Hadden DR. Insulin sensitivity in pre-eclampsia. Br J Obstet Gynecol. 1998;105:1095–1100
  10. Caruso A, Ferrazzani S, De Carolis S, Lucchese A, Lanzone A, De Santis L, et al. Gestational hypertension but not pre-eclampsia is associated with insulin resistance syndrome characteristics. Hum Reprod. 1999;14:219–223
  11. Bartha JL, Romero-Carmona R, Torrejon-Cardoso R, Comino-Delgado R. Insulin, insulin-like growth factor-1, and insulin resistance in women with pregnancy-induced hypertension. Am J Obstet Gynecol. 2002;187:735–740
  12. Fuh MMT, Yin CS, Pei D, Sheu WHH, Jeng CY, Chen YDI, et al. Resistance to insulin-mediated glucose uptake and hyperinsulinemia in women who had preeclampsia during pregnancy. Am J Hypertens. 1995;8:768–771
  13. Nisell H, Erikssen C, Persson B, Carlström K. Is carbohydrate metabolism altered among women who have undergone a preeclamptic pregnancy?. Gynecol Obstet Invest. 1999;48:241–246
  14. Jacober SJ, Morris DA, Sowers JR. Postpartum blood pressure and insulin sensitivity in African-American women with recent preeclampsia. Am J Hypertens. 1994;7:933–936
  15. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol. 1988;158:892–898
  16. Sandoval-Rodriguez T, Jimenez-Solis G, Torres-Zamora M, Garcia-Alonso A, Romero-Lopez J, Valdes-Garcia JJ. Pre-eclampsia in pregnancy. Importance of reclassification. Ginecol Obstet (Mex). 1993;61:283–289
  17. Arroyo P, Casanueva E, Reynoso M. Expected weight for complexion and gestational age. Tables of reference. Ginecol Obstet (Mex). 1985;53:227–231
  18. Caro JF. Clinical review 26: Insulin resistance in obese and nonobese man. J Clin Endocrinol Metab. 1991;73:691–695
  19. American Diabetes Association . Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(Supp.1):S5–S20
  20. Legro RS, Castracane VD, Kauffman RP. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls. Obstet Gynecol Surv. 2004;59:141–154
  21. Tai MM. A mathematical model for the determination of total area under glucose tolerance and other metabolic curves. Diabetes Care. 1994;17:152–154
  22. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes. 1981;30:219–225
  23. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595–1607
  24. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173–194
  25. Bauman WA, Maimen M, Langer O. An association between hyperinsulinemia and hypertension during the third trimester of pregnancy. Am J Obstet Gynecol. 1988;159:446–450
  26. Martinez-Abundis E, Gonzalez-Ortiz M, Cardona-Muñoz EG, Hernandez-Chavez A. Light pre-eclampsia and insulin values at the third trimester of pregnancy. Ginecol Obstet (Mex). 1988;66:227–231
  27. Seely EW, Solomon CG. Insulin resistance and its potential role in pregnancy-induced hypertension. J Clin Endocrinol Metab. 2003;88:2393–2398
  28. Kaaja R, Tikkanen MJ, Vinikka L, Ylikorkala O. Serum lipoproteins, insulin, and urinary prostanoid metabolites in normal and hypertensive pregnant women. Obstet Gynecol. 1995;85:353–356
  29. Kirwan JP, Huston-Presley L, Kalhan SC, Catalano PM. Clinically useful estimates of insulin sensitivity during pregnancy. Diabetes Care. 2001;24:1602–1607
  30. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (Syndrome X). Diabetes. 1992;41:715–722

PII: S0188-4409(06)00090-7

doi: 10.1016/j.arcmed.2005.12.006

Archives of Medical Research
Volume 37, Issue 6 , Pages 749-754 , August 2006

Article Tools

* Image Usage & Resolution